Skip to main content
AAN.com
Brief Communication
July 1, 1992

Memantine prevents HIV coat protein‐induced neuronal injury in vitro

July 1992 issue
42 (7) 1403

Abstract

Studies with in vitro model systems suggest that at least part of the neurologic deficits of human immunodeficiency virus (HIV)-1-associated cognitive/motor complex may stem from neuronal injury mediated by the HIV-1 coat protein gp120. Concurrent activation of N-methyl-D-aspartate (NMDA) receptors is also necessary for gp120 to induce neuronal damage. We studied memantine, a drug that blocks NMDA receptor-operated ion channels, for possible protective effects from gp 120-induced neuronal injury. In identified rat retinal ganglion cells in culture, we found that 2 FM memantine completely prevented the injury engendered by 20 pM gp120. These data suggest that memantine has therapeutic potential as an NMDA antagonist capable of ameliorating neuronal damage associated with gp120.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 42Number 7July 1992
Pages: 1403
PubMed: 1620355

Publication History

Published online: July 1, 1992
Published in print: July 1992

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Stuart A. Lipton, MD, PhD
Laboratory of Cellular and Molecular Neuroscience, Children's Hospital, Departments of Neurology, Children's Hospital, Beth Israel Hospital, Brigham and Women's Hospital, and Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Boston, MA

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Vir2Drug: a drug repurposing framework based on protein similarities between pathogens, Briefings in Bioinformatics, 24, 1, (2022).https://doi.org/10.1093/bib/bbac536
    Crossref
  2. Assessing the potential of repurposing ion channel inhibitors to treat emerging viral diseases and the role of this host factor in virus replication, Biomedicine & Pharmacotherapy, 156, (113850), (2022).https://doi.org/10.1016/j.biopha.2022.113850
    Crossref
  3. Disease-modifying therapy for HIV-related distal symmetrical polyneuropathy (including antiretroviral toxic neuropathy), Cochrane Database of Systematic Reviews, (2020).https://doi.org/10.1002/14651858.CD013716
    Crossref
  4. Viral, Protozoan, and Related Intracranial Infections, Volpe's Neurology of the Newborn, (973-1049.e18), (2018).https://doi.org/10.1016/B978-0-323-42876-7.00034-X
    Crossref
  5. Scaling Synapses in the Presence of HIV, Neurochemical Research, 44, 1, (234-246), (2018).https://doi.org/10.1007/s11064-018-2502-2
    Crossref
  6. N -Methyl- d -Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection , mBio, 8, 2, (2017).https://doi.org/10.1128/mBio.00350-17
    Crossref
  7. Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain, Frontiers in Microbiology, 7, (2016).https://doi.org/10.3389/fmicb.2016.00103
    Crossref
  8. HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment, Nature Reviews Neurology, 12, 4, (234-248), (2016).https://doi.org/10.1038/nrneurol.2016.27
    Crossref
  9. Intravitreal memantine retinal toxicity in rabbits, Archivos de la Sociedad Española de Oftalmología (English Edition), 91, 2, (65-68), (2016).https://doi.org/10.1016/j.oftale.2016.01.003
    Crossref
  10. Toxicidad de memantina intravítrea en retina de conejos, Archivos de la Sociedad Española de Oftalmología, 91, 2, (65-68), (2016).https://doi.org/10.1016/j.oftal.2015.10.005
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Share article link

Share